biosimilarity

The Biosimilar Development Process

4:20

The Biosimilar Development Process
The Basics of Biosimilars

4:12

The Basics of Biosimilars
Biosimilars: Approval Process

2:47

Biosimilars: Approval Process
Biosimilars: Manufacturing and Inherent Variation

3:33

Biosimilars: Manufacturing and Inherent Variation
The Promise of Biosimilars

3:07

The Promise of Biosimilars
Biosimilars: Critical Quality Attributes

3:12

Biosimilars: Critical Quality Attributes
Fast Facts About Efficacy of Biosimilars – Amgen Science

1:08

Fast Facts About Efficacy of Biosimilars – Amgen Science
Biosimilars Interchangeability

2:03

Biosimilars Interchangeability
FDA Review and Approval Process for Biosimilar Medications

1:58

FDA Review and Approval Process for Biosimilar Medications
Data Requirements for Biosimilars

5:20

Data Requirements for Biosimilars
Fast Facts about Biosimilars - Amgen Science

00:43

Fast Facts about Biosimilars - Amgen Science
Increasing the Efficiency of Biosimilar Development Programs (Day 1)

2:55:17

Increasing the Efficiency of Biosimilar Development Programs (Day 1)
Increasing the Efficiency of Biosimilar Development Programs (Day 2)

2:51:28

Increasing the Efficiency of Biosimilar Development Programs (Day 2)
Biosimilars Part 1: History and Biology

18:00

Biosimilars Part 1: History and Biology
The science of biosimilarity: Immunogenicity

5:29

The science of biosimilarity: Immunogenicity
Biosimilars Part 2: Regulatory and Current Status

13:25

Biosimilars Part 2: Regulatory and Current Status
Biosimilars - The Importance of In Vitro Assays for the Development of Biosimilars

8:57

Biosimilars - The Importance of In Vitro Assays for the Development of Biosimilars
Biosimilar and India Regulations

47:11

Biosimilar and India Regulations
The Concept of Interchangeability

4:20

The Concept of Interchangeability
Advances in Hydrogen-Deuterium Exchange Mass Spectrometry That Can Improve Studies of Biosimilars..

45:55

Advances in Hydrogen-Deuterium Exchange Mass Spectrometry That Can Improve Studies of Biosimilars..
Assessing Biosimilarity Based on Ion Signal Statistics in LC/MS Peptide Maps

7:26

Assessing Biosimilarity Based on Ion Signal Statistics in LC/MS Peptide Maps
Innovative Biosimilars Development Strategies

55:44

Innovative Biosimilars Development Strategies
How Biologic Medicines Are Made | Biomanufacturing

3:13

How Biologic Medicines Are Made | Biomanufacturing
BIOSIMILARITY of designed audio for metering display spectral metering

1:24

BIOSIMILARITY of designed audio for metering display spectral metering
IMPLEMENTING CMC STRATEGIES FOR SCALE-UP OPERATIONS IN BIOLOGICS MANUFACTURING

1:12:37

IMPLEMENTING CMC STRATEGIES FOR SCALE-UP OPERATIONS IN BIOLOGICS MANUFACTURING
Malvern MicroCal DSC – Biosimilarity and Batch-to Batch Comparability

4:43

Malvern MicroCal DSC – Biosimilarity and Batch-to Batch Comparability
Step-by-Step Glycan Analysis of a Biologic Therapeutic

4:59

Step-by-Step Glycan Analysis of a Biologic Therapeutic
Webinar - Automated IR-Spectroscopy for Analysis of Protein Biopharmaceuticals RedShiftBio - Pfizer

43:14

Webinar - Automated IR-Spectroscopy for Analysis of Protein Biopharmaceuticals RedShiftBio - Pfizer
MicroCal PEAQ-DSC: the future of protein stability characterization

1:01

MicroCal PEAQ-DSC: the future of protein stability characterization
Target Binding and CDC Induction Between Therapeutic Antibodies | Protocol Preview

2:01

Target Binding and CDC Induction Between Therapeutic Antibodies | Protocol Preview
Live launch of Malvern MicroCal PEAQ-DSC systems

1:00:41

Live launch of Malvern MicroCal PEAQ-DSC systems
Alkem Launches Cetuximab under the Brand Name Cetuxa in India

2:43

Alkem Launches Cetuximab under the Brand Name Cetuxa in India
Mass Spec 2021 Keynote: Albert Heck, Utrecht University

1:10:25

Mass Spec 2021 Keynote: Albert Heck, Utrecht University
6.1. Регуляторные аспекты воспроизведенных препаратов: термины и определения

16:43

6.1. Регуляторные аспекты воспроизведенных препаратов: термины и определения
Rituximab l Classification l BE Study l Side effects & Reactions l Use for Treatment l #facts #viral

11:41

Rituximab l Classification l BE Study l Side effects & Reactions l Use for Treatment l #facts #viral
AAO '22 Late-Breaking Talks: Biosimilar Phase 3 Data and TRUCKEE Update

19:23

AAO '22 Late-Breaking Talks: Biosimilar Phase 3 Data and TRUCKEE Update
Principles of Biosimilarity - Humira v Amgevita

13:34

Principles of Biosimilarity - Humira v Amgevita